ABT
Abbott LaboratoriesHealthcare$102.87
◆ Neutral
Mkt Cap: $178.76B|Float: 1.73B|SI: 1.2%|DTC: 2.4
Data as of market close Apr 2, 2026
IV Rank
96
IV Pctl
78%
HV 20d
1948.0%
52W Range
$101-$137
ATR(14)
$2.32
Exp. Move
±0.3%
P/C Ratio
0.94
Earnings
Apr 16
GEX Negative
DEX Long
Net Put Premium
IV High
Max Pain Above
Exp. Move Narrow
ABT Key Options Data
- IV Rank
- 95.9%
- Total GEX
- $-0.00B
- Total DEX
- $4.7M
- Max Pain
- $105.00
- Expected Move
- ±0.3%
- Put/Call OI
- 0.94
- Net Premium
- $-0.8M
- Spot Price
- $102.87
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-02 | 0 | ±$0.32 | ±0.3% | $102.55 | $103.20 |
| 2026-04-10 | 8 | ±$2.98 | ±2.9% | $99.90 | $105.85 |
| 2026-04-17 | 15 | ±$5.88 | ±5.7% | $97.00 | $108.75 |
| 2026-04-24 | 22 | ±$3.65 | ±3.5% | $99.22 | $106.52 |
| 2026-05-01 | 29 | ±$4.20 | ±4.1% | $98.67 | $107.07 |
| 2026-05-15 | 43 | ±$8.70 | ±8.5% | $94.17 | $111.57 |
Explore ABT options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.